Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Syneos Health, Pfizer Ink New Service Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News

Syneos Health, Pfizer Ink New Service Agreement

Three-year agreement to provide global product development services to support Pfizer's portfolio.

By: Contract Pharma

Contract Pharma Staff

Syneos Health has signed a new three-year agreement with Pfizer to provide global product development services to support Pfizer’s portfolio. Pfizer has the right to extend the term for up to an additional two years. Financial details were not disclosed.

This agreement builds on a longstanding relationship where Syneos Health has provided services across the clinical and commercial continuum to support product development. The company will continue to provide a broad range of services customized to meet Pfizer’s goals across its portfolio, including full service and FSP solutions.

“Our ability to deliver deep therapeutic expertise, while bringing forward insights that can facilitate shorter and more efficient trials, has proven to be advantageous in our work with Pfizer,” said Paul Colvin, President, Syneos Health Clinical Solutions. “This new agreement allows us to continue our collaboration to deliver flexible and innovative solutions. We are pleased to expand our Pfizer relationship to optimize their portfolio and deliver on our shared purpose to change patients’ lives.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics